Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism (Q46058332)

19 December 2017

title

Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism (English)

1 reference

19 December 2017

0 references

13

Alan David Kaye

1 reference

19 December 2017

author name string

Juan Li

1

1 reference

19 December 2017

Peng Zhang

2

1 reference

19 December 2017

Quan-Yu Zhang

3

1 reference

19 December 2017

Shu-Miao Zhang

4

1 reference

19 December 2017

Hai-Tao Guo

5

1 reference

19 December 2017

Hui Bi

6

1 reference

19 December 2017

Yue-Min Wang

7

1 reference

19 December 2017

Xin Sun

8

1 reference

19 December 2017

Jin-Cheng Liu

9

1 reference

19 December 2017

Liang Cheng

10

1 reference

19 December 2017

Qin Cui

11

1 reference

19 December 2017

Shi-Qiang Yu

12

1 reference

19 December 2017

Ding-Hua Yi

14

1 reference

19 December 2017

Jian-Ming Pei

15

1 reference

19 December 2017

language of work or name

1 reference

5 April 2009

1 reference

19 December 2017

published in

Vascular Pharmacology

1 reference

19 December 2017

volume

51

1 reference

19 December 2017

issue

2-3

1 reference

19 December 2017

page(s)

72-77

1 reference

19 December 2017

Endothelin-1 in the lungs of patients with pulmonary hypertension

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

The smooth muscle cell in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

7 January 2021

Pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Effects of endogenous carbon monoxide on collagen synthesis in pulmonary artery in rats under hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Comparison of opioid receptor distributions in the rat ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

The pathology of the early and late stages of primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Small pulmonary arterial vessels of Aymara Indians from the Bolivian Andes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Binding of [3H][D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Expression of functional kappa-opioid receptors on murine dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Anti-arrhythmic effects of kappa-opioid receptor and its changes in ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Role of K+ channels in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

U50,488H depresses pulmonary pressure in rats subjected to chronic hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

The pathobiology of pulmonary hypertension. Endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Effects of continuous infusion of atrial natriuretic peptide on the pulmonary hypertension induced by chronic hypoxia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.03.003

10.1016/J.VPH.2009.03.003

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017